AbstractThe structural diversity and SAR in a series of imidazopyridazine inhibitors of Plasmodium falciparum calcium dependent protein kinase 1 (PfCDPK1) has been explored and extended. The opportunity to further improve key ADME parameters by means of lowering logD was identified, and this was achieved by replacement of a six-membered (hetero)aromatic linker with a pyrazole. A short SAR study has delivered key examples with useful in vitro activity and ADME profiles, good selectivity against a human kinase panel and improved levels of lipophilic ligand efficiency. These new analogues thus provide a credible additional route to further development of the series
To combat drug resistance, new chemical entities are urgently required for use in next generation an...
The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing ...
On the basis of our recent results on a novel series of imidazopyridazine-based antimalarials, we fo...
AbstractThe structural diversity and SAR in a series of imidazopyridazine inhibitors of Plasmodium f...
AbstractA series of imidazopyridazines which are potent inhibitors of Plasmodium falciparum calcium-...
A series of imidazopyridazines which are potent inhibitors of Plasmodium falciparum calcium-dependen...
ABSTRACT: A structure-guided design approach using a homology model of Plasmodium falciparum calcium...
Recent studies on 3,6-diphenylated imidazopyridazines have demonstrated impressive in vitro activity...
Recent studies on 3,6-diphenylated imidazopyridazines have demonstrated impressive in vitro activity...
Imidazopyridazine compounds are potent, ATP-competitive inhibitors of calcium-dependent protein kina...
Development of a class of bicyclic inhibitors of the Plasmodium falciparum cyclic GMP-dependent prot...
PfCDPK1 is a Plasmodium falciparum calcium-dependent protein kinase, which has been identified as a ...
Imidazopyridazine compounds are potent, ATP-competitive inhibitors of calcium-dependent protein kina...
International audience3,6-Disubstituted imidazo[1,2-b]pyridazine derivatives were synthesized to ide...
A novel class of imidazopyridazines identified from whole cell screening of a SoftFocus kinase libra...
To combat drug resistance, new chemical entities are urgently required for use in next generation an...
The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing ...
On the basis of our recent results on a novel series of imidazopyridazine-based antimalarials, we fo...
AbstractThe structural diversity and SAR in a series of imidazopyridazine inhibitors of Plasmodium f...
AbstractA series of imidazopyridazines which are potent inhibitors of Plasmodium falciparum calcium-...
A series of imidazopyridazines which are potent inhibitors of Plasmodium falciparum calcium-dependen...
ABSTRACT: A structure-guided design approach using a homology model of Plasmodium falciparum calcium...
Recent studies on 3,6-diphenylated imidazopyridazines have demonstrated impressive in vitro activity...
Recent studies on 3,6-diphenylated imidazopyridazines have demonstrated impressive in vitro activity...
Imidazopyridazine compounds are potent, ATP-competitive inhibitors of calcium-dependent protein kina...
Development of a class of bicyclic inhibitors of the Plasmodium falciparum cyclic GMP-dependent prot...
PfCDPK1 is a Plasmodium falciparum calcium-dependent protein kinase, which has been identified as a ...
Imidazopyridazine compounds are potent, ATP-competitive inhibitors of calcium-dependent protein kina...
International audience3,6-Disubstituted imidazo[1,2-b]pyridazine derivatives were synthesized to ide...
A novel class of imidazopyridazines identified from whole cell screening of a SoftFocus kinase libra...
To combat drug resistance, new chemical entities are urgently required for use in next generation an...
The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing ...
On the basis of our recent results on a novel series of imidazopyridazine-based antimalarials, we fo...